teprotide has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forbes, JM; Harcourt, BE; Sourris, KC | 1 |
| Loon, N; Meyer, T; Morelli, E; Myers, BD; Peters, W | 1 |
1 review(s) available for teprotide and Diabetic Nephropathies
| Article | Year |
|---|---|
A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?
Topics: Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Microcirculation; Reactive Oxygen Species; Teprotide; Vitamins | 2009 |
1 trial(s) available for teprotide and Diabetic Nephropathies
| Article | Year |
|---|---|
Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Cell Membrane; Cell Membrane Permeability; Dextrans; Diabetic Nephropathies; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Male; Middle Aged; Oligopeptides; Proteins; Teprotide | 1990 |